Capricor Therapeutics CAPR Business Segments — Other Nonoperating Income Expense

Similar metrics at other companies

QURESingle Reportable — Other Nonoperating Income Expense

$199K-96.1%

ONTOSingle Reportable — Other Nonoperating Income Expense

-$1.25M-3,346%

SRRKSingle Reportable — Other Nonoperating Income Expense

$3.49M+248%

MCRISingle Reportable — Other Nonoperating Income Expense

-$598K-89.2%

NCLHSingle Reportable — Other Nonoperating Income Expense

$40.7M+266%

ACLSSingle Reportable — Nonoperating Income Expense

$2.68M-31.8%

Questions, answered.

What is Capricor Therapeutics's business segments — other nonoperating income expense?

Capricor Therapeutics (CAPR) reported business segments — other nonoperating income expense of -$73K in Q1 2026.

How has Capricor Therapeutics's business segments — other nonoperating income expense changed year-over-year?

Capricor Therapeutics's business segments — other nonoperating income expense increased by 47.2% year-over-year, from -$138.19K to -$73K.

What does business segments — other nonoperating income expense mean?

This captures miscellaneous financial gains or losses that fall outside the scope of core business operations and standard interest-related activities. It includes items such as foreign exchange fluctuations or minor asset disposals. Tracking this helps isolate the impact of peripheral financial events on the overall bottom line.